Arsenic in Drinking Water and Cerebrovascular Disease, Diabetes Mellitus, and Kidney Disease in Michigan: a Standardized Mortality Ratio Analysis

Overview

Journal Environ Health

Publisher Biomed Central

Specialty Environmental Health

Date 2007 Feb 6

PMID 17274811

Citations 97

Authors

Jaymie R Meliker

Robert L Wahl

Lorraine L Cameron

Jerome O Nriagu

Affiliations

Soon will be listed here.

Abstract

Background: Exposure to arsenic concentrations in drinking water in excess of 300 microg/L is associated with diseases of the circulatory and respiratory system, several types of cancer, and diabetes; however, little is known about the health consequences of exposure to low-to-moderate levels of arsenic (10-100 microg/L).

Methods: A standardized mortality ratio (SMR) analysis was conducted in a contiguous six county study area of southeastern Michigan to investigate the relationship between moderate arsenic levels and twenty-three selected disease outcomes. Disease outcomes included several types of cancer, diseases of the circulatory and respiratory system, diabetes mellitus, and kidney and liver diseases. Arsenic data were compiled from 9251 well water samples tested by the Michigan Department of Environmental Quality from 1983 through 2002. Michigan Resident Death Files data were amassed for 1979 through 1997 and sex-specific SMR analyses were conducted with indirect adjustment for age and race; 99% confidence intervals (CI) were reported.

Results: The six county study area had a population-weighted mean arsenic concentration of 11.00 microg/L and a population-weighted median of 7.58 microg/L. SMR analyses were conducted for the entire six county study area, for only Genesee County (the most populous and urban county), and for the five counties besides Genesee. Concordance of results across analyses is used to interpret the findings. Elevated mortality rates were observed for both males (M) and females (F) for all diseases of the circulatory system (M SMR, 1.11; CI, 1.09-1.13; F SMR, 1.15; CI, 1.13,-1.17), cerebrovascular diseases (M SMR, 1.19; CI, 1.14-1.25; F SMR, 1.19; CI, 1.15-1.23), diabetes mellitus (M SMR, 1.28; CI, 1.18-1.37; F SMR, 1.27; CI, 1.19-1.35), and kidney diseases (M SMR, 1.28; CI, 1.15-1.42; F SMR, 1.38; CI, 1.25-1.52).

Conclusion: This is some of the first evidence to suggest that exposure to low-to-moderate levels of arsenic in drinking water may be associated with several of the leading causes of mortality, although further epidemiologic studies are required to confirm the results suggested by this ecologic SMR analysis.

Citing Articles

The effect of consuming bread contaminated with heavy metals on cardiovascular disease and calculating its risk assessment.

Angali K, Farhadi M, Neisi A, Cheraghian B, Ahmadi M, Takdastan A Sci Rep. 2025; 15(1):2710.

PMID: 39837925 PMC: 11751297. DOI: 10.1038/s41598-025-86240-3.

Invited Perspective: Is It Time to Revisit the Allowable Maximum Contaminant Limit for Arsenic in Public Drinking Water?.

Meliker J, Gopang M Environ Health Perspect. 2024; 132(10):101303.

PMID: 39440944 PMC: 11498016. DOI: 10.1289/EHP16196.

Long-Term Exposure to Arsenic in Community Water Supplies and Risk of Cardiovascular Disease among Women in the California Teachers Study.

Medgyesi D, Bangia K, Spielfogel E, Fisher J, Madrigal J, Jones R Environ Health Perspect. 2024; 132(10):107006.

PMID: 39440943 PMC: 11498017. DOI: 10.1289/EHP14410.

Update of the risk assessment of inorganic arsenic in food.

Schrenk D, Bignami M, Bodin L, Chipman J, Del Mazo J, Grasl-Kraupp B EFSA J. 2024; 22(1):e8488.

PMID: 38239496 PMC: 10794945. DOI: 10.2903/j.efsa.2024.8488.

Arsenic in Drinking Water and Diabetes.

Shakya A, Dodson M, Artiola J, Ramirez-Andreotta M, Root R, Ding X Water (Basel). 2023; 15(9).

PMID: 37886432 PMC: 10601382. DOI: 10.3390/w15091751.

References

Simeonova P, Luster M . Arsenic and atherosclerosis. Toxicol Appl Pharmacol. 2004; 198(3):444-9. DOI: 10.1016/j.taap.2003.10.018. View

Slotnick M, Meliker J, Nriagu J . Effects of time and point-of-use devices on arsenic levels in Southeastern Michigan drinking water, USA. Sci Total Environ. 2006; 369(1-3):42-50. DOI: 10.1016/j.scitotenv.2006.04.021. View

Chi I, BLACKWELL R . A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Am J Epidemiol. 1968; 88(1):7-24. DOI: 10.1093/oxfordjournals.aje.a120869. View

Lu T, Liu J, LeCluyse E, Zhou Y, Cheng M, Waalkes M . Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol Sci. 2001; 59(1):185-92. DOI: 10.1093/toxsci/59.1.185. View

Cerhan J, Cantor K, Williamson K, Lynch C, Torner J, Burmeister L . Cancer mortality among Iowa farmers: recent results, time trends, and lifestyle factors (United States). Cancer Causes Control. 1998; 9(3):311-9. DOI: 10.1023/a:1008877204830. View

Walton F, Harmon A, Paul D, Drobna Z, Patel Y, Styblo M . Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol. 2004; 198(3):424-33. DOI: 10.1016/j.taap.2003.10.026. View

Guha Mazumder D, Steinmaus C, Bhattacharya P, von Ehrenstein O, Ghosh N, Gotway M . Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology. 2005; 16(6):760-5. DOI: 10.1097/01.ede.0000181637.10978.e6. View

Chen C, Chiou H, Chiang M, Lin L, Tai T . Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol. 1996; 16(4):504-10. DOI: 10.1161/01.atv.16.4.504. View

Tsai S, Wang T, Ko Y . Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health. 1999; 54(3):186-93. DOI: 10.1080/00039899909602258. View

10.

Steinmaus C, Moore L, Biggs M, Smith A . Arsenic in drinking water and bladder cancer. Cancer Invest. 2000; 18(2):174-82. DOI: 10.3109/07357900009038249. View

11.

Rahman M, Tondel M, Ahmad S, Axelson O . Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol. 1998; 148(2):198-203. DOI: 10.1093/oxfordjournals.aje.a009624. View

12.

Stiernstrom E, Holmberg S, Thelin A, Svardsudd K . A prospective study of morbidity and mortality rates among farmers and rural and urban nonfarmers. J Clin Epidemiol. 2001; 54(2):121-6. DOI: 10.1016/s0895-4356(00)00287-0. View

13.

Bates M, Rey O, Biggs M, Hopenhayn C, Moore L, Kalman D . Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol. 2004; 159(4):381-9. DOI: 10.1093/aje/kwh054. View

14.

Kim M, Nriagu J, Haack S . Arsenic species and chemistry in groundwater of southeast Michigan. Environ Pollut. 2002; 120(2):379-90. DOI: 10.1016/s0269-7491(02)00114-8. View

15.

Smith A, Goycolea M, Haque R, Biggs M . Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol. 1998; 147(7):660-9. DOI: 10.1093/oxfordjournals.aje.a009507. View

16.

Meliker J, Slotnick M, AvRuskin G, Kaufmann A, Fedewa S, Goovaerts P . Individual lifetime exposure to inorganic arsenic using a space-time information system. Int Arch Occup Environ Health. 2006; 80(3):184-97. DOI: 10.1007/s00420-006-0119-2. View

17.

Chiou H, HUANG W, Su C, Chang S, Hsu Y, Chen C . Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997; 28(9):1717-23. DOI: 10.1161/01.str.28.9.1717. View

18.

Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha A, Smith A . Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology. 2000; 11(6):673-9. DOI: 10.1097/00001648-200011000-00010. View

19.

Milton A, Rahman M . Respiratory effects and arsenic contaminated well water in Bangladesh. Int J Environ Health Res. 2002; 12(2):175-9. DOI: 10.1080/09603120220129346. View

20.

Bates M, Smith A, Cantor K . Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol. 1995; 141(6):523-30. DOI: 10.1093/oxfordjournals.aje.a117467. View